1. Home
  2. POWW vs SLN Comparison

POWW vs SLN Comparison

Compare POWW & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMMO Inc.

POWW

AMMO Inc.

HOLD

Current Price

$1.96

Market Cap

242.8M

Sector

Industrials

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$7.12

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWW
SLN
Founded
1990
1994
Country
United States
United Kingdom
Employees
81
116
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.8M
236.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
POWW
SLN
Price
$1.96
$7.12
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$2.40
$42.60
AVG Volume (30 Days)
496.3K
367.8K
Earning Date
02-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.56
N/A
Revenue Next Year
$0.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$4.19
52 Week High
$2.23
$8.40

Technical Indicators

Market Signals
Indicator
POWW
SLN
Relative Strength Index (RSI) 43.03 53.04
Support Level $1.89 $5.91
Resistance Level $1.98 $7.21
Average True Range (ATR) 0.07 0.45
MACD -0.01 -0.11
Stochastic Oscillator 23.08 27.33

Price Performance

Historical Comparison
POWW
SLN

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: